Loss of IL-15 receptor α alters the endurance, fatigability,and metabolic characteristics of mouse fast skeletal muscles

Journal of Clinical Investigation

Volumn 121, Issue 8, 2011, Pages 3120-3132

  Pistilli, Emidio E ^a,g   Bogdanovich, Sasha ^a,h   Garton, Fleur ^b   Yang, Nan ^b   Gulbin, Jason P ^c   Conner, Jennifer D ^d   Anderson, Barbara G ^d,e   Quinn, LeBris S ^d,e   North, Kathryn ^b   Ahima, Rexford S ^f   Khurana, Tejvir S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c AUSTRALIAN INSTITUTE OF SPORT   (Australia)

^d VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g WEST VIRGINIA UNIVERSITY   (United States)

^h UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15 RECEPTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOGENESIS; CALCIUM HOMEOSTASIS; CELL NUCLEUS; CONTROLLED STUDY; EXERCISE; FEMALE; GENETIC ASSOCIATION; IN VIVO STUDY; MALE; MOBILIZATION; MOUSE; MUSCLE CELL; MUSCLE CONTRACTION; MUSCLE EXERCISE; MUSCLE FATIGUE; MUSCLE METABOLISM; MUSCLE MITOCHONDRION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SKELETAL MUSCLE;

ANIMALS; CALCIUM; HOMEOSTASIS; HUMANS; INTERLEUKIN-15; INTERLEUKIN-15 RECEPTOR ALPHA SUBUNIT; ISOMETRIC CONTRACTION; MALE; MICE; MICE, KNOCKOUT; MUSCLE FATIGUE; MUSCLE FIBERS, FAST-TWITCH; MUSCLE, SKELETAL; OXYGEN; PHENOTYPE; PHYSICAL ENDURANCE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79960993380     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI44945     Document Type: Article

References (67)

1. Grabstein KH, et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science. 1994;264(5161):965- 968. (Pubitemid 24196167)
2. Giri JG, et al. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. Embo J. 1995;14(15):3654-3663.
3. Giri JG, et al. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. Embo J. 1994;13(12):2822-2830. (Pubitemid 24191692)
4. Pistilli EE, Siu PM, Alway SE. Interleukin-15 responses to aging and unloading-induced skeletal muscle atrophy. Am J Physiol Cell Physiol. 2007;292(4):C1298-C1304. (Pubitemid 46631721)
5. Nielsen AR, et al. Expression of interleukin-15 in human skeletal muscle effect of exercise and muscle fibre type composition. J Physiol. 2007;584(pt 1):305-312. (Pubitemid 47500557)
6. Marzetti E, et al. Changes in IL-15 expression and death-receptor apoptotic signaling in rat gastrocnemius muscle with aging and life-long calorie restriction. Mech Ageing Dev. 2009;130(4):272-280.
7. Quinn LS, Anderson BG, Strait-Bodey L, Wolden-Hanson T. Serum and muscle interleukin-15 levels decrease in aging mice: correlation with declines in soluble interleukin-15 receptor alpha expression. Exp Gerontol. 2010;45(2):106-112.
8. Quinn LS, Haugk KL, Grabstein KH. Interleukin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology. 1995;136(8):3669-3672.
9. Furmanczyk PS, Quinn LS. Interleukin-15 increases myosin accretion in human skeletal myogenic cultures. Cell Biol Int. 2003;27(10):845-851. (Pubitemid 37117402)
10. Quinn LS, Anderson BG, Drivdahl RH, Alvarez B, Argiles JM. Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders. Exp Cell Res. 2002;280(1):55-63. (Pubitemid 35230367)
11. Pistilli EE, Alway SE. Systemic elevation of interleukin-15 in vivo promotes apoptosis in skeletal muscles of young adult and aged rats. Biochem Biophys Res Commun. 2008;373(1):20-24.
12. Carbo N, et al. Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats. Br J Cancer. 2000;83(4):526-531. (Pubitemid 30487868)
13. Figueras M, et al. Interleukin-15 is able to suppress the increased DNA fragmentation associated with muscle wasting in tumour-bearing rats. FEBS Lett. 2004;569(1-3):201-206. (Pubitemid 38844618)
14. He Y, et al. IL-15 receptor deletion results in circadian changes of locomotor and metabolic activity. J Mol Neurosci. 2010;41(2):315-321.
15. Wu X, He Y, Hsuchou H, Kastin AJ, Rood JC, Pan W. Essential role of interleukin-15 receptor in normal anxiety behavior. Brain Behav Immun. 2010;24(8):1340-1346.
16. Pistilli EE, et al. Interleukin-15 and interleukin-15R alpha SNPs and associations with muscle, bone, and predictors of the metabolic syndrome. Cytokine. 2008;43(1):45-53.
17. Riechman SE, Balasekaran G, Roth SM, Ferrell RE. Association of interleukin-15 protein and interleukin- 15 receptor genetic variation with resistance exercise training responses. J Appl Physiol. 2004;97(6):2214-2219. (Pubitemid 39552462)
18. Di Renzo L, et al. Normal Weight Obese syndrome: role of single nucleotide polymorphism of IL-1 5Ralpha and MTHFR 677C - >T genes in the relationship between body composition and resting metabolic rate. Eur Rev Med Pharmacol Sci. 2006;10(5):235-245. (Pubitemid 44932334)
19. Di Renzo L, et al. Role of interleukin-15 receptor alpha polymorphisms in normal weight obese syndrome. Int J Immunopathol Pharmacol. 2009;22(1):105-113.
20. Nielsen AR, et al. Association between interleukin-15 and obesity: interleukin-15 as a potential regulator of fat mass. J Clin Endocrinol Metab. 2008;93(11):4486-4493. (Pubitemid 352789551)
21. Bergamaschi C, et al. Intracellular interaction of interleukin-15 with its receptor alpha during production leads to mutual stabilization and increased bioactivity. J Biol Chem. 2008;283(7):4189-4199.
22. Dubois S, Mariner J, Waldmann TA, Tagaya Y. IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity. 2002;17(5):537-547. (Pubitemid 35351500)
23. Budagian V, Bulanova E, Paus R, Bulfone-Paus S. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 2006;17(4):259-280. (Pubitemid 44038618)
24. Rubinstein MP, et al. Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}. Proc Natl Acad Sci U S A. 2006;103(24):9166-9171. (Pubitemid 43902550)
25. Dubois S, Patel HJ, Zhang M, Waldmann TA, Muller JR. Preassociation of IL-15 with IL-15R alpha- IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action. J Immunol. 2008;180(4):2099-2106.
26. Stoklasek TA, Schluns KS, Lefrancois L. Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo. J Immunol. 2006;177(9):6072- 6080. (Pubitemid 44628822)
27. Lodolce JP, et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity. 1998;9(5):669-676. (Pubitemid 28557595)
28. Kennedy MK, et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med. 2000;191(5):771-780.
29. Budagian V, et al. Natural soluble interleukin-15Ralpha is generated by cleavage that involves the tumor necrosis factor-alpha-converting enzyme (TACE/ADAM17). J Biol Chem. 2004;279(39):40368-40375. (Pubitemid 39287624)
30. Mortier E, et al. Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins. J Biol Chem. 2006;281(3):1612-1619.
31. Dubois S, et al. Natural splicing of exon 2 of human interleukin-15 receptor alpha-chain mRNA results in a shortened form with a distinct pattern of expression. J Biol Chem. 1999;274(38):26978-26984.
32. Anderson DM, et al. Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes. J Biol Chem. 1995;270(50):29862-29869. (Pubitemid 26002153)
33. Bulanova E, et al. Soluble Interleukin IL-15Ralpha is generated by alternative splicing or proteolytic cleavage and forms functional complexes with IL-15. J Biol Chem. 2007;282(18):13167-13179. (Pubitemid 47100509)
34. Quinn LS, Anderson BG, Strait-Bodey L, Stroud AM, Argiles JM. Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am J Physiol Endocrinol Metab. 2009;296(1):E191-E202.
35. Sieck GC, Sacks RD, Blanco CE, Edgerton VR. SDH activity and cross-sectional area of muscle fibers in cat diaphragm. J Appl Physiol. 1986;60(4):1284-1292. (Pubitemid 16028428)
36. Chen ZX, Pervaiz S. Involvement of cytochrome c oxidase subunits Va and Vb in the regulation of cancer cell metabolism by Bcl-2. Cell Death Differ. 2009;17(3):408-420.
37. Allen DL, Roy RR, Edgerton VR. Myonuclear domains in muscle adaptation and disease. Muscle Nerve. 1999;22(10):1350-1360. (Pubitemid 29468418)
38. Burleigh IG. Observations on the number of nuclei within the fibres of some red and white muscles. J Cell Sci. 1977;23:269-284. (Pubitemid 8048754)
39. Van Dyke AL, Cote ML, Wenzlaff AS, Land S, Schwartz AG. Cytokine SNPs: comparison of allele frequencies by race and implications for future studies. Cytokine. 2009;46(2):236-244.
40. Chan S, Seto JT, MacArthur DG, Yang N, North KN, Head SI. A gene for speed: contractile properties of isolated whole EDL muscle from an alphaactinin- 3 knockout mouse. Am J Physiol Cell Physiol. 2008;295(4):C897-C904.
41. Lin J, et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature. 2002;418(6899):797-801.
42. Burke RE. The structure and function of motor units. In: Engel AG, Franzini - Armstrong C, eds. Myology. 3rd ed. New York, New York, USA: McGraw - Hill; 2004:104-118.
43. Celichowski J, Grottel K. Twitch/tetanus ratio and its relation to other properties of motor units. Neuroreport. 1993;5(3):201-204. (Pubitemid 24026232)
44. Rassier DE, Tubman LA, MacIntosh BR. Inhibition of Ca2+ release in rat atrophied gastrocnemius muscle. Exp Physiol. 1997;82(4):665-676. (Pubitemid 27363851)
45. Mason SD, et al. Loss of skeletal muscle HIF-1alpha results in altered exercise endurance. PLoS Biol. 2004;2(10):e288.
46. Narkar VA, et al. AMPK and PPARdelta agonists are exercise mimetics. Cell. 2008;134(3):405-415.
47. Fischer MD, et al. Definition of the unique human extraocular muscle allotype by expression profiling. Physiol Genomics. 2005;22(3):283-291. (Pubitemid 41356360)
48. Fischer MD, et al. Expression profiling reveals metabolic and structural components of extraocular muscles. Physiol Genomics. 2002;9(2):71-84. (Pubitemid 135707414)
49. Porter JD, et al. Extraocular muscle is defined by a fundamentally distinct gene expression profile. Proc Natl Acad Sci U S A. 2001;98(21):12062- 12067. (Pubitemid 32959826)
50. Puigserver P, Spiegelman BM. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev. 2003;24(1):78-90. (Pubitemid 36223280)
51. Handschin C, et al. Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals. J Biol Chem. 2007;282(41):30014-30021. (Pubitemid 350035265)
52. Leberer E, Pette D. Immunochemical quantification of sarcoplasmic reticulum Ca-ATPase, of calsequestrin and of parvalbumin in rabbit skeletal muscles of defined fiber composition. Eur J Biochem. 1986;156(3):489-496.
53. Paolini C, et al. Reorganized stores and impaired calcium handling in skeletal muscle of mice lacking calsequestrin-1. J Physiol. 2007;583(pt 2):767-784. (Pubitemid 47343505)
54. Wu X, Pan W, Stone KP, Zhang Y, Hsuchou H, Kastin AJ. Expression and signaling of novel IL15Ralpha splicing variants in cerebral endothelial cells of the blood-brain barrier. J Neurochem. 2010;114(1):122-129.
55. Hanisch UK, et al. Mouse brain microglia express interleukin-15 and its multimeric receptor complex functionally coupled to Janus kinase activity. J Biol Chem. 1997;272(46):28853-28860.
56. Kubota T, Brown RA, Fang J, Krueger JM. Interleukin-15 and interleukin-2 enhance non-REM sleep in rabbits. Am J Physiol Regul Integr Comp Physiol. 2001;281(3):R1004-R1012.
57. Doherty TJ. Invited review: aging and sarcopenia. J Appl Physiol. 2003;95(4):1717-1727. (Pubitemid 37169320)
58. Grounds MD, Radley HG, Lynch GS, Nagaraju K, De Luca A. Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiol Dis. 2008;31(1):1-19.
59. Varela GM, et al. Inhibition of ADRP prevents diet-induced insulin resistance. Am J Physiol Gastrointest Liver Physiol. 2008;295(3):G621-G628.
60. Wong T, Hildebrandt MA, Thrasher SM, Appleton JA, Ahima RS, Wu GD. Divergent metabolic adaptations to intestinal parasitic nematode infection in mice susceptible or resistant to obesity. Gastroenterology. 2007;133(6):1979- 1988. (Pubitemid 350180809)
61. Pistilli EE, et al. Targeting the Activin Type IIB Receptor to Improve Muscle Mass and Function in the mdx Mouse Model of Duchenne Muscular Dystrophy. Am J Pathol. 2011;178(3):1287-1297.
62. Burke RE, Levine DN, Tsairis P, Zajac FE 3rd. Physiological types and histochemical profiles in motor units of the cat gastrocnemius. J Physiol. 1973;234(3):723-748.
63. Brooks SV, Faulkner JA. Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol. 1988;404:71-82.
64. Lynch GS, Hinkle RT, Chamberlain JS, Brooks SV, Faulkner JA. Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old. J Physiol. 2001;535(pt 2):591-600. (Pubitemid 32825693)
65. Degens H, Turek Z, Hoofd LJ, Van't Hof MA, Binkhorst RA. The relationship between capillarisation and fibre types during compensatory hypertrophy of the plantaris muscle in the rat. J Anat. 1992;180(pt 3):455-463.
66. Yang N, et al. ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet. 2003;73(3):627-631. (Pubitemid 37076274)
67. Huttley GA, Wilson SR. Testing for concordant equilibria between population samples. Genetics. 2000;156(4):2127-2135. (Pubitemid 32001269)